Study guide

10.5 Postpartum Blues, Depression & EPDS Screening

AMCB Certified Nurse-Midwife CNM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral

2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts

2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy

3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy

4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss

4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care

5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance

5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion

6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation

6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair

7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture

8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation

8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications

9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage

9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation

10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health

10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis

11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination

11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes

12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days

12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days

13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization

13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening

14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation

14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral

15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders

15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome

16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause

16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis

17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions

17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking

18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity

18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care

10.5 Postpartum Blues, Depression & EPDS Screening

Key Takeaways Explain This Topic AI

Postpartum blues affects 50 to 80 percent of patients, peaks on days 4 to 5, resolves by day 10 to 14, and preserves maternal functioning and infant attachment.

A prior history of major depression or anxiety is the single strongest predictor of postpartum depression, carrying a 30 to 50 percent recurrence risk.

Depression-related insomnia in the postpartum period is characterized by inability to sleep even when the infant is sleeping.

An EPDS score of 13 or higher indicates probable major depression requiring diagnostic evaluation and treatment, while 10 to 12 warrants supportive counseling and re-screening.

Any non-zero score on EPDS Question 10 mandates a same-day in-person suicide risk assessment regardless of the total score.

Last updated: September 2026

Perinatal mood and anxiety disorders (PMADs) represent the most frequent complication of childbearing, surpassing gestational diabetes, preeclampsia, and postpartum hemorrhage in overall population prevalence. In the United States, maternal mental health conditions—encompassing suicide and substance overdose—constitute the leading cause of overall maternal mortality in the first year postpartum, accounting for over 23% of pregnancy-related deaths. The certified nurse-midwife (CNM) plays an indispensable role in universal screening, early clinical recognition, destigmatizing mental health counseling, safe lactation psychopharmacology, and emergency crisis intervention.

The Perinatal Mental Health Continuum

Maternal psychological well-being exists along a broad spectrum, ranging from benign, transient physiological mood lability to life-threatening psychiatric emergencies. Distinguishing where a patient lies along this continuum is essential for timely, life-saving care. The Perinatal Mental Health Spectrum

├── Postpartum Blues ──> 50-80% prevalence; onset days 2-3, peaks days 4-5, resolves by day 10-14; normal bonding

├── Postpartum Depr. ──> 10-15% prevalence; onset 4-12 weeks; pervasive anhedonia, guilt, sleep deficit; EPDS ≥13

├── Postpartum OCD ──> Intrusive egodystonic thoughts of infant harm; intense maternal guilt; NO psychosis

└── Postpartum Psych. ──> 0.1-0.2% (1-2/1,000); onset days 3-14; egosyntonic delusions, hallucinations; EMERGENCY

Biological & Neuroendocrine Pathophysiology

The acute postpartum period represents one of the most abrupt endocrine transitions in human physiology:

Steroid Hormone Withdrawal: Circulating levels of estradiol and progesterone fall precipitously by over 100-fold within 48 to 72 hours following delivery of the placenta, reaching hypogonadal levels.

GABAergic Neurotransmission: Progesterone is metabolized into allopregnanolone , a potent positive allosteric modulator of GABA A \text{GABA}_\text{A} GABA A ​ receptors. The rapid postpartum withdrawal of allopregnanolone alters GABA A \text{GABA}_\text{A} GABA A ​ receptor subunit composition, destabilizing neural inhibition and predisposing susceptible individuals to acute anxiety, panic, and dysphoria.

HPA Axis & Thyroid Function: The hypothalamic-pituitary-adrenal (HPA) axis undergoes dynamic reset, with blunted adrenocortical reactivity. Concurrently, postpartum thyroiditis affects 5% to 10% of women, presenting with transient thyrotoxicosis followed by hypothyroidism that can mimic or exacerbate depressive symptoms.

Circadian Rhythm Disruption: Severe, fragmented maternal sleep architecture compounds neurobiological vulnerability, impairing prefrontal cortical regulation of emotional processing.

  • Postpartum Blues ("Baby Blues")
  • Epidemiology & Clinical Course

Prevalence: Affects 50% to 80% of postpartum individuals across diverse cultures and socioeconomic strata. It is considered a physiological, self-limiting biological adjustment reaction rather than a psychiatric disorder.

Timeline: Symptoms typically emerge on postpartum days 2 to 3 , reach peak intensity around days 4 to 5 , and resolve spontaneously within 10 to 14 days (maximum 2 weeks).

Clinical Manifestations

Marked emotional lability, rapid mood swings, and unexpected tearfulness ("crying spells for no apparent reason").

Mild, fleeting anxiety, subjective fatigue, irritability, insomnia, and feeling overwhelmed by routine newborn tasks.

The Defining Clinical Feature: Preserved maternal functioning and intact infant attachment. The mother remains emotionally bonded to her infant, derives joy from the baby, and retains the cognitive and physical capacity to provide newborn care.

Midwifery Management

Provide reassurance and anticipatory guidance, normalizing the blues as a common neurohormonal adaptation.

Validate maternal emotions and alleviate self-blame.

Mobilize familial, partner, and community support systems to assist with domestic chores and infant care.

Prioritize protected maternal sleep periods (uninterrupted 4- to 5-hour sleep blocks).

Mandatory Clinical Follow-Up: Educate the patient and partner that if symptoms persist beyond 14 days postpartum , or if symptoms progressively worsen, she must contact the clinic immediately for formal evaluation for postpartum depression.

  • Postpartum Depression (PPD)
  • Epidemiology & Risk Stratification

Postpartum depression affects approximately 10% to 15% of childbearing women in community samples, with rates exceeding 25% among adolescent mothers and economically disadvantaged populations.

  • High-Yield Clinical Risk Factors Risk Magnitude & Midwifery Consideration
  • Prior History of MDD or Anxiety Single strongest predictor (30% to 50% recurrence risk without prophylaxis)
  • Prior Episode of Postpartum Depression 50% to 70% risk of recurrence in subsequent pregnancies
  • Prenatal Depressive Symptoms High likelihood of direct persistence into the postpartum year
  • Poor Social / Partner Support Markedly increases maternal isolation, chronic stress, and exhaustion
  • Intimate Partner Violence (IPV) Independent predictor of persistent, severe postpartum depression

Adverse Life Events / Birth Trauma Unplanned emergency cesarean, severe PPH, neonatal intensive care (NICU) admission

Diagnostic Criteria (DSM-5-TR: Major Depressive Episode with Peripartum Onset)

Diagnostic criteria require the presence of ≥5 of the following 9 symptoms during the same 2-week period , representing a clear change from previous functioning. At least one of the symptoms must be depressed mood or pervasive anhedonia :

Depressed mood most of the day, nearly every day (feelings of intense sadness, emptiness, hopelessness, or uncontrollable weeping).

Markedly diminished interest or pleasure (anhedonia) in all or almost all activities, including an inability to feel affection, warmth, or joy when interacting with the infant.

Significant unintentional weight change or marked change in appetite.

Insomnia or hypersomnia: Critical Diagnostic Nuance: PPD insomnia is characterized by the maternal inability to sleep even when the infant is sleeping soundly .

Observable psychomotor agitation or psychomotor retardation.

Chronic fatigue or pervasive loss of energy nearly every day.

Feelings of worthlessness or excessive, inappropriate guilt (e.g., "I am a terrible mother," "my baby would be better off without me").

Diminished ability to think, concentrate, or make simple decisions regarding daily care.

Recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt.

Universal Screening: The Edinburgh Postnatal Depression Scale (EPDS)

Professional guidelines from ACOG, the American Academy of Pediatrics (AAP), and the American College of Nurse-Midwives (ACNM) mandate universal postpartum screening using a validated instrument.

Screening Cadence

Universal screening should occur at the comprehensive postpartum visit (3 to 12 weeks).

Screening should be integrated into antepartum care, routine pediatric well-child encounters (at 1, 2, 4, and 6 months), and any acute postpartum follow-up visits.

The EPDS Instrument

The Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report questionnaire assessing maternal mood over the preceding 7 days . Unlike general depression inventories (such as the Beck Depression Inventory), the EPDS de-emphasizes somatic symptoms (appetite changes, sleep deprivation, physical fatigue) that naturally occur in healthy postpartum individuals, focusing on affective and cognitive manifestations.

Each item is scored from 0 to 3, yielding a maximum total score of 30.

  • EPDS Total Score Clinical Interpretation Mandatory Midwifery Action
  • 0 to 9 Low risk / normal Reassure, provide anticipatory guidance, continue routine screening

10 to 12 Possible mild depression Supportive counseling, psychoeducation, close follow-up, re-screen in 2–4 weeks

≥13 Probable Major Depression Comprehensive diagnostic evaluation, initiate psychotherapy and/or pharmacotherapy

Question 10 > 0 SUICIDE RISK TRIGGER Immediate, same-day suicide risk assessment , safety plan, and psychiatric consult

[!CRITICAL] AMCB Core Safety Rule — Question 10: Question 10 on the EPDS states: "The thought of harming myself has occurred to me." Any score other than "Never" ( score 1, 2, or 3 ) represents an immediate clinical red flag. Regardless of the total overall score (even if the total score is 3 or 4), a positive Question 10 mandates an immediate, same-day, in-person clinical safety assessment evaluating suicidal intent, plans, access to lethal means, and immediate psychiatric risk!

Loading diagram... Clinical Decision Algorithm: Triaging Perinatal Mental Health Disorders